Discover South Australia’s truly remarkable health and medical capabilities.
You can engage with some of the brightest people in biotech and clinical trials, digital health and innovation in health as well as ageing well and explore why more and more organisations are choosing Adelaide, South Australia, as the ideal base to grow their business.
To learn more about how we can grow South Australia's industry, view the Health and Medical Sector Plan.
It's all here for you
- Watch webinar videos
- Delivering from research to commercialisation
- Seamless end-to-end clinical trails
- Ageing well around the world
- Developing medtech and digital soultions
- Collaboration is in our DNA
- Cutting-edge research and training
- Up to 43.4% cashback for R&D expenses
- In good company
- It's all happening in South Australia
- Let’s talk
Watch webinar videos
Delivering from research to commercialisation
The centrepiece of South Australia’s health and medical industries is Adelaide BioMed City - one of the largest health precincts in the Southern Hemisphere.
We have the proven ability to support successful clinical trials and drive digital health solutions.
Our health & aged care sector - which has grown into a $400 million dollar export industry - provides a solid foundation for developing products and services in ageing well.
We have world leading capabilities in data analytics, machine learning and research that powers sophistication across sectors like health and medical.
As we prepare for the coming technology revolution and work in a changing world, our infrastructure, safety and security provide one of the best places in the world to base your business.
Seamless end-to-end clinical trials
We’re the ideal place to partner in developing and trialling pharmaceuticals with fast ethics approval through private HRECs, one of the largest Phase I facilities in Australia as well as delivering a full suite of clinical research and bioanalytical services. Local clinical trials are further supported by strong government financial incentives of up to 43.5% cashback for R&D expenses.
In addition, our universities and research institutions have a strong focus on drug development including the University of South Australia’s Centre for Cancer Biology as well as the South Australian Health and Medical Research Institute.
Ageing well around the world
South Australia has strong capabilities in delivering best practice in treating chronic conditions while galvanising clinician-scientists, consumer groups and health services to support an enviable ageing well sector.
Our universities are at the forefront of finding solutions through institutes like the Global Centre for Modern Ageing and the Centre of Research Excellence in Frailty and Healthy Ageing.
And we have a burgeoning commercial industry, based in Adelaide, helping jurisdictions around the world support their ageing populations, including the industry-driven Ageing Well International globalising local ageing expertise.
Developing medtech and digital health solutions
South Australia provides international medical technology companies with an opportunity to expand their manufacturing footprint, through engaging former automotive industry workers and supply chain companies with ISO 13485 certification
Our universities bring together industry, researchers and clinicians through initiatives like the Medical Device Partnering Program while the Australian Advanced Materials Manufacturing Facility prints complex metal parts of medical and dental devices.
Combined with South Australia’s cost-effectiveness, large talent pool of IT professionals and a growing cluster of start-ups and scale-ups, global digital health companies are able to rapidly establish successful Asia-Pacific operations from South Australia.
Our local ecosystem includes the Australian Institute for Machine Learning, the Digital Health Research Centre, the International Centre for Point-of-care Testing, and the GP Partners network of doctors trialling digital health initiatives. In addition, Adelaide is served with a 10 gigabit fibre network for business.
Collaboration is in our DNA
Developing and enhancing collaborations the industry connectivity initiative (ICI), which will support industry led sector growth.
An innovation neighbourhood in the heart of Adelaide, Lot Fourteen is focused on growing the industries of the future, from space and defence to cyber security, machine learning, health, and medical. It’s home to innovative companies like Life Whisperer employing non-invasive, artificial intelligence driven image analysis for IVF and Presagen creating diagnostic web-based medical imaging software.
Tonsley Innovation District
Tonsley is successfully attracting high-profile investors including Siemens, ZEISS and SAGE Group as well as research, development and training from Flinders University and TAFE SA.
The precinct features the Medical Device Research Institute that’s bringing together industry, researchers and clinicians to develop future medtech solutions.
Connect at 10 Gigabits
Ten Gigabit Adelaide is a revolutionary high-speed, high-performance fibre optic data network that is being rolled out to commercial buildings across the City of Adelaide. The network enables businesses and organisations to share and receive high volumes of data at phenomenal 10Gbps data speeds.
In addition, GigCity Adelaide allows businesses access to affordable internet with speeds from one gigabit right up to 10 gigabit at GigCity locations across Adelaide and the regions, that includes Lot Fourteen, Technology Park and Tonsley Innovation District.
Cutting-edge research and training
University of Adelaide, Flinders University, and the University of South Australia are our three, globally-recognised public universities which all have a strong focus on health and medical training, research and commercialisation.
In addition, our universities’ institutes are making globally-significant contributions in their field, including but not limited to:
Up to 43.5% cashback for R&D expenses
Up to 43.5% of R&D costs will be reimbursed in cash to eligible companies with an aggregated annual turnover of less than A$20 million (approx. US$15 million). A substantial tax offset is offered to all other eligible entities.
Costs covered include clinical trials, analytics, study drug manufacture, prototype manufacturing, the development of new algorithms, and many other types of R&D.
- Avance Clinical and Agilex Biolabs
- Carina Biotech
- Carl Zeiss Vision
- CMAX Clinical Research
- Ellex Medical Lasers
- LBT Innovations
- Mayne Pharma
- Personify Care
- Presagen - Life Whisperer
- Scientific Sarstedt
- TGR BioSciences
- Thermo Fisher
- Trajan Nutrition
- Yuhan ANZ
It's all happening in South Australia
News, highlights and insights for trade and investment in South Australia.
If you are a health and medical business interested in investing in South Australia contact
Director Health and Medical Industries
Department for Trade and Investment
Phone +61 8 8463 6191
Explore opportunities for investing in South Australia's health and medical industries sector.